BCM
NXTM

Bluefin Capital Management’s NxStage Medical Inc. NXTM Stock Holding History

Bluefin Capital Management’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-73,409
Closed -$1.16M – 807
2015
Q3 		$1.16M Buy
+73,409
New +$1.18M 0.07% 176

Other funds holding NXTM

GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bluefin Capital Management's NXTM Position: Q4 2015 in Review

Bluefin Capital Management sold out of NxStage Medical Inc. (NXTM) in Q4 2015, closing a stake of 73,409 shares — an estimated $1.16M sold.

Bluefin Capital Management first reported a position in NXTM in Q3 2015 and held it in 1 quarter. The position peaked at $1.16M in Q3 2015. 140 funds tracked by Wall St. Rank hold NXTM as of Q4 2015.

  • Bluefin Capital Management reported no remaining NxStage Medical Inc. position as of Q4 2015 after selling out during the quarter.
  • Bluefin Capital Management sold 73,409 NxStage Medical Inc. shares in Q4 2015, an estimated $1.16M.
  • Bluefin Capital Management first reported a position in NxStage Medical Inc. in Q3 2015 and held it in 1 quarter.
  • Bluefin Capital Management's NxStage Medical Inc. position peaked at $1.16M in Q3 2015.
  • 140 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q4 2015.

Based on Bluefin Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.